Connection

FENG LI to Calcium-Calmodulin-Dependent Protein Kinase Kinase

This is a "connection" page, showing publications FENG LI has written about Calcium-Calmodulin-Dependent Protein Kinase Kinase.
  1. Pharmacological inhibition of CaMKK2 with the selective antagonist STO-609 regresses NAFLD. Sci Rep. 2017 09 18; 7(1):11793.
    View in: PubMed
    Score: 0.136
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.